Inflammation and fibrosis play a central role in the development of heart failure with preserved ejection fraction (HFpEF). We previously showed that low-level, transcutaneous stimulation of the vagus nerve at the tragus (LLTS) is anti-inflammatory. We investigated the effect of chronic intermittent LLTS on cardiac inflammation, fibrosis and diastolic dysfunction in a rat model of HFpEF. Dahl salt-sensitive (DS) rats were randomized in three groups: low salt (LS, 0.3% NaCl; n = 12; control group without stimulation) and high salt (HS, 4% NaCl) with either active (n = 18) or sham (n = 18) LLTS at 7 weeks of age. After 6 weeks of diet (baseline), sham or active LLTS (20 Hz, 2 mA, 0.2 ms) was implemented for 30 min daily for 4 weeks. Echocardiography was performed at baseline and 4 weeks after treatment (endpoint). At endpoint, left ventricle (LV) histology and gene expression were examined. After 6 weeks of diets, HS rats developed hypertension and LV hypertrophy compared to LS rats. At endpoint, LLTS significantly attenuated blood pressure elevation, prevented the deterioration of diastolic function and improved LV circumferential strain, compared to the HS sham group. LV inflammatory cell infiltration and fibrosis were attenuated in the HS active compared to the HS sham group. Pro-inflammatory and pro-fibrotic genes (tumour necrosis factor, osteopontin, interleukin (IL)-11, were differentially altered in the two groups. Chronic intermittent LLTS ameliorates diastolic dysfunction, and attenuates cardiac inflammation and fibrosis in a rat model of HFpEF, suggesting that LLTS may be used clinically as a novel non-invasive neuromodulation therapy in HFpEF.
INTRODUCTION
Heart failure with preserved ejection fraction (HFpEF) has become a major public health concern, accounting for approximately half of all heart failure patients (Lam, Donal, Kraigher-Krainer, & Vasan, 2011; Shah et al., 2017) . Hospitalizations related to HFpEF are increasing and outcomes of patients with HFpEF are poor, yet no treatment has been shown to decrease morbidity and mortality (Butler et al., 2014; Fonarow et al., 2007) . Recent animal and human studies suggest that a systemic proinflammatory state, produced by comorbidities, including ageing and hypertension, plays a central role in the development of HFpEF (Franssen et al., 2016; Frantz et al., c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society 2018; Paulus & Tschope, 2013) . This proinflammatory state leads to left ventricular (LV) fibrosis, diastolic dysfunction and HFpEF (Paulus & Tschope, 2013) . Therefore, attenuating the proinflammatory state and suppressing cardiac fibrosis is an attractive therapeutic target for HFpEF. Importantly, reduction of inflammation and fibrosis normalized LV diastolic function and improved survival in a rat model of HFpEF, without attenuation of LV hypertrophy, suggesting that inflammation and fibrosis are not only causative in HFpEF, but also potentially reversible (Gallet et al., 2016) .
The anti-inflammatory effects of vagus nerve stimulation (VNS) have been well established (Abboud, Harwani, & Chapleau, 2012; Pavlov & Tracey, 2015) . VNS can be accomplished transcutaneously by stimulating the auricular branch of the vagus nerve (Fallgatter et al., 2003) . Using this approach, Wang et al. demonstrated suppression of the inflammatory response, attenuation of cardiac fibrosis and improvement in cardiac function in a canine model of chronic myocardial infarction (Wang et al., 2014) . In addition, transcutaneous VNS suppressed lipopolysaccharide-induced serum inflammatory cytokines in rats with endotoxaemia (Zhao et al., 2012) and reduced ischaemia-induced inflammation and attenuated tissue injury in a rat model of acute ischaemic brain injury (Ay, Nasser, Simon, & Ay, 2016) . In a recent proof-of-concept study in humans, low-level transcutaneous VNS (LLTS) significantly suppressed systemic inflammatory cytokines in patients with paroxysmal atrial fibrillation (Stavrakis et al., 2015) .
Collectively, these data suggest that LLTS may be used as a novel nonpharmacological treatment modality for cardiovascular conditions, where inflammation plays a key role, including HFpEF.
The Dahl salt-sensitive (DS) rat model is a well-established model of HFpEF and has been widely used to test new treatments for HFpEF (Valero-Munoz, Backman, & Sam, 2017) . DS rats fed with high salt diet develop progressive hypertension and LV hypertrophy and, eventually, HFpEF (Doi et al., 2000; Valero-Munoz et al., 2017) . Importantly, the degree of hypertension depends on the salt amount in the diet and the age of initiation of the high salt diet (Doi et al., 2000) . In the present study, we aimed to investigate the effects of chronic, intermittent LLTS on diastolic dysfunction, inflammation and fibrosis in a DS rat model of HFpEF.
METHODS

Ethical approval
The experimental design of all animal experiments was approved by the Institutional Animal Care and Use Committee of the University of Oklahoma Health Science Center (protocol number 16-106). All the experiments were carried out according to the guidelines laid down by the University of Oklahoma Health Sciences Center Animal Welfare Committee and conform to the previously described principles and regulations for animal experimentation of Experimental Physiology (Grundy, 2015) , and all steps were taken to minimize the animals' pain and suffering during the experiments. All animals were obtained from Charles River Laboratories (Wilmington, MA, USA).
Experimental animals
Forty-eight male DS rats were fed with 0.3% NaCl (low salt, LS) diet until 7 weeks of age. As shown in Figure 1a , rats at 7 weeks of age were randomly assigned in a 3:1 ratio to receive either 4% NaCl diet [high salt (HS) diet] or 0.3% NaCl diet [low salt (LS) diet] for 6 weeks.
Twelve DS rats fed LS diet comprised the control group. Water was provided ad libitum. HS diet DS rats were randomized in a 1:1 ratio to either active (n = 18) or sham (n = 18) LLTS starting at 13 weeks of age.
Heart rate, blood pressure (BP) and body weight were measured and echocardiography was performed at 6 weeks after LS/HS diet (baseline) and 4 weeks after treatment (endpoint). BP measurements were obtained non-invasively using the tail-cuff method (PowerLab Data
New Findings
• What is the central question of this study?
What is the effect of chronic intermittent low-level transcutaneous vagus nerve stimulation on cardiac inflammation, fibrosis and diastolic dysfunction in a rat model of heart failure with preserved ejection fraction?
• What is the main finding and its importance?
In salt-sensitive rats fed with high salt diet, low-level transcutaneous vagus nerve stimulation significantly attenuated blood pressure elevation, ameliorated diastolic function, and attenuated left ventricular inflammation and fibrosis compared to the sham group.
Further studies to examine the efficacy of this novel treatment in humans are warranted.
Acquisition System, ADInstruments, Sydney, Australia). Three animals (1 in each group) died after baseline examination but before 4 weeks endpoint and were not included in the final analysis. At the end of 4 weeks, the animals were killed with isoflurane 5% by inhalation and the heart was harvested for analysis ( Figure 1a ).
LLTS
LLTS (20 Hz frequency, 0.2 ms pulse duration, 2 mA amplitude) was delivered through a TENS device (InTENSity TM Twin Stim R , Current
Solutions LLC, Austin, TX, USA) for 30 min daily over a 4 week period, under 2% isoflurane anaesthesia, by placing two oppositely charged magnetic electrodes over the auricular concha region (Figure 1b, d ), inside (cathode) and outside (anode), respectively, at each ear, as previously described (Wang et al., 2015) . In the HS sham group, the electrodes were placed on the auricular margin ( Figure 1c, d ), which is devoid of vagus innervation (Peuker & Filler, 2002) . Consistent with previous transcutaneous VNS studies where sham stimulation was used as the comparison group (Ay et al., 2016; Wang et al., 2015) , we did not include a HS diet, no stimulation, control group in this study. The LLTS stimulation parameters were selected empirically, based on the observation that 1 h of LLTS decreased serum inflammatory cytokines in our previous study in humans (Stavrakis et al., 2015) . Furthermore, we elected to stimulate for 30 min daily for 4 weeks, given that this regimen normalized glucose levels in diabetic rats in a recent study (Wang et al., 2015) . During acute stimulation (averaging all the rats during the baseline and endpoint sessions), active LLTS resulted in a small, but significant drop in heart rate (baseline: 356 ± 15 bpm vs.
active LLTS: 348 ± 14 bpm; P = 0.01), suggesting that vagal fibres were stimulated ( Figure 1e ).
Echocardiography
Echocardiography (Acuson SC2000, Siemens, Malvern, PA, USA ) was performed at 6 weeks after LS/HS diet (baseline) and 4 weeks after treatment (endpoint) to assess diastolic function, under axis LV images were obtained using a 10 MHz transducer and pulsewave Doppler spectra of mitral inflow (E and A waves), as well as mitral annulus tissue Doppler spectra were recorded. The early diastolic mitral annulus velocity (e ′ ) was used to assess diastolic function as previously described (Horgan, Watson, Glezeva, & Baugh, 2014) .
Medial and lateral mitral annular e ′ velocities were obtained and averaged. In addition, the ratio of early to late mitral inflow Doppler velocity (E/A ratio) and the E/e ′ ratio, which correlate with LV diastolic relaxation and stiffness and LV filling pressures, respectively (Horgan et al., 2014) , were calculated. LV strain was obtained off-line, in a blinded fashion, using a speckle-tracking algorithm (Acuson SC2000 eSie VVI TM , Siemens). Due to the poor reproducibility of apical long axis views in rodents, which would render longitudinal strain inaccurate (Bonios et al., 2011) , we only analysed circumferential strain. LV mass was calculated based on M-mode measurements, as previously described (Pawlush, Moore, Musch, & Davidson, 1993) .
This method demonstrates very good correlation with actual LV mass measurements at necropsy (Pawlush et al., 1993) .
Histological measurements
At the end of the experiment, LV tissue was quickly excised and fixed in 4% formalin for histological study. Paraffin blocks were processed and cut into 5 m sections for haematoxylin-eosin (HE) and Masson's trichrome staining. The number of infiltrating mononuclear cells was counted in a blinded manner by examining five fields per section with the use of a microscope (Olympus BX51, Waltham, MA, USA) at ×400 magnification in each slide, as previously described (Yamamoto et al., 2018) . Fibrosis was quantified using the BIOQUANT software (Bioquant Image Analysis Corp., Nashville, TN, USA).
Myocardial gene expression analysis
Resected LV sections were immediately frozen on ice and then stored at −80 • C until homogenization. RNA was isolated from homogenized LV samples according to the manufacturer's instructions, using a combined Trizol and RNAqueous 4PCR Kit (Thermo Fisher Scientific, Waltham, MA, USA) method, with DNase added to remove contaminant DNA. Then, cDNA was generated using a RT 2 First Strand Kit (Qiagen Sciences Inc., Germantown, MD, USA) according to the manufacturer's instructions. Gene expression of inflammatory cytokines was quantified, relative to the geometric mean of five stable reference genes, using a Qiagen RT 2 Profiler PCR Array (PARN-150Z).
To evaluate the effect of active relative to sham treatment, fold-change gene expression relative to control (LS group) was calculated using the ΔΔC t method (Yoshida et al., 2014) . The investigators performing the gene expression assays were blinded to group assignment. Based on previous investigations showing activation of the cholinergic antiinflammatory pathway by VNS (Pavlov & Tracey 2015) , we hypothesized that LLTS would alter the expression of pro-inflammatory genes related to this pathway.
Statistical analysis
Continuous variables are presented as the mean ± standard deviation.
Baseline data and histological data at endpoint were compared among 
Average e ′ (cm s −1 ) 6.6 ± 1.3 7.3 ± 1.3 7.6 ± 1.3 7.0 ± 1.2 0.17 0.26
Average E/e ′ ratio 9.0 ± 1.4 9.1 ± 1.5 8.9 ± 1.5 9.3 ± 1.6 0.99 0.42
Circumferential strain (%) −23.9 ± 2.9 −22.2 ± 3.7 −22.5 ± 3.4 −21.8 ± 3.9 0.16 0.58 BP, blood pressure; HS, high salt; LS, low salt; LV, left ventricle.
groups with one-way analysis of variance (ANOVA). Echocardiographic parameters were compared among groups using repeated measures ANOVA. All pair-wise testing was adjusted for multiple comparisons by
Tukey's method. Gene expression data were analysed using a Wilcoxon rank-sum test and were adjusted for multiple comparisons using the Benjamini-Hochberg method. Correlations between gene expression data and echocardiographic parameters and BP were examined using Spearman's rank-order correlation. Statistical significance was set at P < 0.05. All analyses were performed using SAS 9.3 software (SAS Institute, Inc., Cary, NC, USA).
RESULTS
Development of hypertension and LV hypertrophy in HS rats
The baseline characteristics measured after 6 weeks of diet in the LS and HS groups are summarized in Table 1 . Rats in the HS group developed increased BP (systolic BP: 129.4 ± 14.6 vs.
114.1 ± 17.4 mmHg, P < 0.05; diastolic BP: 89.9 ± 12.7 vs.
70.1 ± 14.1 mmHg, P < 0.05) and LV hypertrophy (interventricular septum: 2.3 ± 0.2 vs. 2.0 ± 0.1 mm, P < 0.05) compared to LS rats.
Baseline body weight, heart rate and LV ejection fraction were similar among the groups. There were no statistical differences between the two HS groups at baseline (Table 1) .
LLTS significantly attenuated blood pressure elevation
The results at endpoint (4 weeks after treatment) are summarized in 115.0 ± 21.0 mmHg, respectively, P < 0.05) (Figure 2a, b) .
LLTS significantly reduced LV hypertrophy
At endpoint, LV wall thickness in the HS sham group was significantly increased compared to the LS group (interventricular septum: 2.7 ± 0.2 vs. 2.1 ± 0.2 mm, respectively, P < 0.05; LV posterior wall: 2.8 ± 0.3 vs.
2.3 ± 0.2 mm, respectively, P < 0.05) (Figure 2d 0.8 ± 0.1 g, respectively; P = 0.001), while LLTS prevented this process (0.9 ± 0.1 vs. 1.2 ± 0.2 g; P = 0.001).
LLTS prevented the deterioration of LV diastolic function and improved LV strain
Representative pulse wave Doppler showing the E (early filling) and A (late filling) wave in each group at endpoint are shown in Figure 3a .
At endpoint, diastolic function in the HS sham group significantly deteriorated compared to the LS group, as indicated by an increase in the E/A ratio (1.7 ± 0.3 vs. 1.4 ± 0.2, respectively; P < 0.05), consistent with pseudonormalization pattern as seen with progression of diastolic dysfunction (Maragiannis & Nagueh, 2015) (Figure 3b ). Likewise, there was an increase in the E/e ′ ratio in the HS sham group compared to the LS group (11.1 ± 2.3 vs. 8.0 ± 1.7, respectively; P < 0.05), consistent with elevated LA pressures (Maragiannis & Nagueh, 2015) ( Figure 3c ). In addition, LV circumferential strain deteriorated in −25.8 ± 4.2%, respectively; P < 0.05) (Figure 3d ). Chronic intermittent LLTS significantly prevented the deterioration of diastolic function in the HS active group as compared to the HS sham group (E/A ratio: 1.4 ± 0.2 vs. 1.7 ± 0.3, respectively; P < 0.05; E/e ′ ratio:
8.1 ± 2.1 vs. 11.1 ± 2.3, respectively, P < 0.05) and improved LV circumferential strain (−24.1 ± 4.1% vs. −19.7 ± 4.1%, respectively; P < 0.05) (Figure 3b-d) . The LV ejection fraction remained unchanged in both HS groups (Figure 3e ).
LLTS attenuated LV inflammatory cell infiltration and fibrosis
Representative images of the LV inflammatory cell infiltration are shown in Figure 4a . Quantitative analysis revealed that HS diet induced a significant increase of LV inflammatory cell infiltration in the HS sham group compared to the LS group (22.7 ± 4.1 vs. 6.5 ± 1.7 mm −2 , respectively, P < 0.05) (Figure 4c ). However, active LLTS significantly decreased LV inflammatory cell infiltration in the HS active compared to the HS sham group (16.0 ± 2.9 vs. 22.7 ± 4.1 mm −2 , respectively, P < 0.05) (Figure 4c ).
Representative images of the fibrosis areas are shown in Figure 4b .
Quantitative analysis revealed that active LLTS significantly decreased LV fibrosis in the HS active group compared to the HS sham group (2.5 ± 1.2% vs. 4.0 ± 2.1%, respectively, P < 0.05), to the levels seen in the LS group (2.3 ± 1.5%) (Figure 4d ). 
LLTS induced changes in myocardial gene expression
DISCUSSION
In this study, chronic intermittent LLTS for 4 weeks significantly attenuated cardiac functional and structural remodelling in a rat model of HFpEF. As expected, HS diet induced significant BP elevation, LV hypertrophy and diastolic dysfunction. However, 4 weeks of intermittent daily LLTS significantly attenuated systolic and diastolic BP elevation and improved LV diastolic dysfunction induced by HS diet. Inflammation and fibrosis represent the major mechanisms underlying cardiac remodelling in HFpEF (Franssen et al., 2016; Frantz et al., 2018; Paulus & Tschope, 2013) . Comorbidities, such as ageing, obesity, hypertension and diabetes induce a systemic pro-inflammatory state, which leads to recruitment of macrophages and monocytes into the heart. These inflammatory cells contribute to LV fibrosis by promoting the differentiation of fibroblasts into myofibroblasts through the release of transforming growth factor (TGF)- (Frantz et al., 2018; Paulus & Tschope, 2013) . The resulting increase in LV collagen content is a major contributor to the increase in passive myocardial fibre stiffness, which eventually leads to diastolic dysfunction and HFpEF. Importantly, it has been recently shown that the number of macrophages in the heart increase both in animal models and in humans with HFpEF (Hulsmans et al., 2018) . Collectively, these data indicate that macrophages and their secreted proteins play a central role in cardiomyocyte hypertrophy and HFpEF progression (Frantz et al., 2018) . Consistent with these data, we have shown that inflammatory cell infiltration in the heart and LV fibrosis were increased in HS rats compared to LS rats, while LLTS attenuated this effect and ameliorated diastolic dysfunction. Moreover, our data suggest that early intervention targeting inflammation and cardiac fibrosis may prevent the deterioration of heart function and prevent the development of HFpEF.
VNS exerts prominent anti-inflammatory effects (Abboud et al., 2012; Pavlov & Tracey, 2015) . Current evidence suggests that the vagus nerve provides the efferent and possibly the afferent limb of the cholinergic anti-inflammatory pathway, by which the brain modulates inflammation (Pavlov & Tracey, 2015) . Consistent with the anti-inflammatory effects of VNS, we have recently shown in a first-inman clinical trial that in patients with drug-refractory atrial fibrillation, LLTS for just 1 h significantly suppressed atrial fibrillation and decreased systemic inflammatory cytokines (Stavrakis et al., 2015) .
Studies also showed that short-term LLTS significantly suppressed ventricular arrhythmias, decreased cardiac and systemic inflammation, attenuated cardiac fibrosis and improved ventricular function both in a chronic myocardial infarction canine model (Wang et al., 2014) and in patients with myocardial infarction undergoing primary percutaneous coronary intervention (Yu et al., 2017) . Importantly, VNS exhibits memory, whereby short periods of stimulation result in long-term anti-inflammatory effects (Koopman et al., 2016) . In a recent study in patients with rheumatoid arthritis, VNS for 1 min up to 4 times a day led to an improvement in disease severity and reduction in (Koopman et al., 2016) . In addition, 30 min of LLTS per day for 4 weeks normalized glucose levels in diabetic rats (Wang et al., 2015) . Notably, the neural processing elements of the cardiac autonomic nervous system also demonstrate memory to VNS (Salavatian et al., 2016) , which may also contribute to the cardioprotective effects of LLTS in our study. In the present study, short-term, intermittent LLTS, delivered daily for 4 weeks significantly suppressed cardiac inflammation and fibrosis, attenuated BP elevation and improved LV hypertrophy and diastolic dysfunction in a rat model of HFpEF. Collectively, these data raise the intriguing possibility that short periods of LLTS may result in a long-lasting anti-inflammatory and anti-fibrotic effect, which in turn may translate into improved clinical outcomes in patients with HFpEF.
HFpEF is characterized by autonomic imbalance with increased sympathetic nerve activity, which is closely associated with diastolic dysfunction (Aikawa et al., 2017; Grassi et al., 2009) , while clinical studies have shown that sympathetic hyperactivity contributes to the development of diastolic dysfunction in patients with hypertension and to disease progression in patients with HFpEF (Florea & Cohn, 2014) . Consistent with our results, a recent study revealed that right cervical VNS decreased sympathetic activity and attenuated the HS diet-induced increase of BP in DS rats (Annoni et al., 2015) . The mechanism of this effect involves inhibition of central sympathetic outflow (Annoni et al., 2015) . We, and others, have previously shown that VNS, even at subthreshold levels not causing bradycardia, exerted antiadrenergic effects, by injuring the sympathetic neurons in the stellate ganglia (Chinda et al., 2016; Sha et al., 2011) . Moreover, VNS attenuated cardiac remodelling and suppressed sympathoexcitation in a guinea-pig model of HFpEF induced by constriction of the thoracic aorta leading to chronic pressure overload ). In addition, recent studies in humans have shown that LLTS suppresses sympathetic nerve activity (Clancy et al., 2014; Deuchars et al., 2018) . Notably, LLTS inhibited noradrenaline release from cardiac sympathetic nerves, dilated cardiac microcirculatory vessels and increased exercise tolerance in patients with coronary artery disease (Zamotrinsky, Afanasiev, Karpov, & Cherniavsky, 1997; Zamotrinsky, Kondratiev, & de Jong, 2001) . Importantly, the anti-adrenergic effects of VNS have been shown to impact basal and reflex function within the intrinsic cardiac nervous system . In light of the autonomic imbalances and impaired autonomic reflexes in HFpEF (Deuchars et al., 2018; Grassi et al., 2009 ), which in turn are associated with adverse neural remodelling in multiple neural circuits within the neural hierarchy for cardiac control, we speculate that LLTS targets specific elements within the intrinsic cardiac autonomic nervous system to stabilize excessive reflex responses, which are responsible for disease progression (Florea & Cohn, 2014) , thereby mitigating efferent output. It is also likely that LLTS improves diastolic function by both a direct effect on the myocardium related to inflammation and by reducing BP through its anti-adrenergic effects. The degree to which each of these mechanisms contributes The mechanism of the effect of LLTS in our study may be related to changes in myocardial gene expression, insofar as key pro-fibrotic and pro-inflammatory genes were differentially altered.
Previously, pressure overload increased IL-18 and osteopontin gene and protein expression in mice, resulting in cardiac fibrosis and diastolic dysfunction (Yu et al., 2009) . In another study, IL-18 mediated cardiac hypertrophy in rabbits with pressure overload (Yoshida et al., 2014) . Moreover, recent studies in murine models of HFpEF and humans with the disease identified osteopontin as an important mediator in the interaction between macrophages and fibroblasts, where macrophages activate the proliferation of myofibroblasts and production of collagen, which then leads to fibrosis-mediated cardiac stiffness and eventually HFpEF (Hulsmans et al., 2018) . In addition, IL-11 is a crucial determinant of cardiac fibrosis (Schafer et al., 2017) .
In our study, myocardial gene expression of IL-23A, IL-18, IL-11
and osteopontin correlated positively with circumferential strain (i.e.
higher gene expression of these pro-inflammatory and pro-fibrotic genes predicted a poorer circumferential strain). Collectively, these data suggest that LLTS may have attenuated the effects of HS diet and prevented the development of diastolic dysfunction in our study by suppressing the myocardial expression of pro-inflammatory and pro-fibrotic genes. Further studies are warranted to elucidate the exact mechanism of LLTS-mediated amelioration of cardiac fibrosis and hypertrophy.
Study limitations
In the present study, we used 4% NaCl diet, instead of 8%, as was originally described (Doi et al., 2000; Valero-Munoz et al., 2017) , and thus the animals did not develop overt signs of heart failure.
However, one of the caveats of the DS model for HFpEF is that the BP levels achieved are non-physiological (>175 mmHg), which limits its clinical applicability (Valero-Munoz et al., 2017) . Therefore, we opted to feed the HS rats with 4% NaCl diet to achieve BP levels seen in humans with HFpEF and mimic an early stage of HFpEF, as indicated by worsening diastolic function and LV strain, as well as increased cardiac inflammation and fibrosis. In this study, it is not possible to differentiate between the effects of regression of LV hypertrophy and reduction of inflammation and fibrosis on diastolic dysfunction. Nonetheless, it has been previously shown that improvement in diastolic dysfunction can occur without regression of LV hypertrophy in a murine model of HFpEF (Wilson, De Silva, Sato, Izumiya, & Sam, 2009) and that interferon-regulates cardiac hypertrophy independent of BP (Garcia et al., 2012) , collectively suggesting that improvement in LV inflammation may result in enhanced diastolic function. Further studies are required to investigate the degree to which each of these mechanisms contributes to amelioration of diastolic dysfunction. We did not perform cardiac autonomic activity recordings in this study.
Given the role of autonomic dysfunction in HFpEF (Aikawa et al., 2017; Grassi et al., 2009) , further studies were warranted to study the effects of LLTS on cardiac autonomic nerve activity in HFpEF models. We only evaluated a fixed set of stimulation parameters for LLTS in our study (frequency 20 Hz, pulse duration 0.2 ms, amplitude 2 mA). These parameters likely activated vagal afferent fibres (Ardell et al., 2017) . Future studies should focus on the impact of different stimulation parameters on the observed outcomes. Animal models do not recapitulate all the features of HFpEF, including the integrative complexity of the related comorbidities, such as ageing and diabetes (Butler et al., 2014 
Clinical implications
HFpEF represents a therapeutic challenge, as no pharmacological therapy has been shown to improve outcomes in patients with this condition (Butler et al., 2014) . Neuromodulation, by exploiting the plasticity of the neural tissue to obtain therapeutic benefit without damage to the myocardium or nerves, has become an emerging therapeutic modality for the treatment of arrhythmias and other cardiovascular diseases (Hou, Zhou, & Po, 2016) . VNS through an implantable device has been used successfully in a preliminary clinical trial in patients with rheumatoid arthritis (Koopman et al., 2016) . Our proof-of-concept results establish the first evidence of the effects of LLTS in HFpEF and provide the basis for the design of human studies using this modality to target selected populations with HFpEF. Even though a recent large trial using VNS in patients with heart failure with reduced ejection fraction (HFrEF) failed to show a beneficial effect (Gold et al., 2016) , another trial in the same patient population, but using different stimulation parameters, demonstrated efficacy (Premchand et al., 2014) , highlighting the importance of optimization of the stimulation parameters to obtain a beneficial effect. Specifically, mechanistic studies have suggested that the optimal stimulation parameters for VNS are at the point at which afferent and efferent fibres are activated in a balanced manner, i.e. the afferent-driven decreases in central parasympathetic drive are counteracted by direct activation of the cardiac parasympathetic efferent projections to the intrinsic cardiac autonomic nervous system and the heart, resulting in a relatively neutral heart rate response (Ardell et al., 2017) .
Consistent with this notion, a recent study of LLTS (30 Hz, 10-50 mA, 200 s, which was slightly below the sensory threshold) in healthy volunteers showed a significant decrease in sympathetic nerve activity without a change in heart rate (Clancy et al., 2014) . In addition, IL-1 blockade with anakinra in patients with HFpEF improved peak oxygen consumption in a recent randomized cross-over trial (Van Tassell et al., 2014) . In support of the notion that autonomic stimulation may be an attractive non-pharmacological approach to treat patients with HFpEF, an ongoing clinical study (ANTHEM-HFpEF) is designed to evaluate the feasibility, tolerability and safety of right cervical VNS in patients with symptomatic HFpEF (DiCarlo et al., 2018) .
Conclusion
Chronic intermittent LLTS significantly improved cardiac diastolic dysfunction and attenuated cardiac inflammation and fibrosis in a rat model of HFpEF. These data suggest that LLTS may be used clinically as a novel non-invasive neuromodulation therapy to treat patients with 
